University of Colorado Division of Hematology
M

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

By University of Colorado Division of Hematology FEATURING Manali Kamdar
By University of Colorado Division of Hematology FEATURING Manali Kamdar
251 views
April 8, 2024

Chapters

FDA Approved Bispecific Antibodies for B-cell Lymphoma

00:00

Long-term Follow-up of Glofitamab in Treatment

02:45

Mosunetuzumab & Polatuzumab for Refractory Large B-Cell Lymphoma

04:37

Comparing CAR-T & CD20 Bispecific T-Cell Engagers

07:47

Frontline Treatment with Axi-cel & Glofitamab

10:39

Indolent Follicular Lymphoma Treatment Updates

13:48

Managing High-risk Mantle Cell Lymphoma

21:16

CLL Treatment Advances & Richter's Transformation Data

28:05

Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Recommended

AUTOPLAY
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.3K views

·

8 months ago
16:57

ASCO® 2024 Summary: "Lymphoma Highlights"

2024 ASCO® Annual Meeting Insights Hub

B. D. Cheson

1.2K views

·

4 months ago
22:29

1L Therapy in CLL: What Are the Best Options?

SOHO Brazil 2024

J. Burger

812 views

·

4 months ago
22:11

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

SOHO Brazil 2024

A. Zelenetz

543 views

·

4 months ago
35:12

Clinical Practice Updates in CLL/SLL

Integrity CE

M. Cortese, D. Wallace, A. Niu

315 views

·

3 months ago
13:07

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Moffitt Cancer Center

J. Chavez

816 views

·

8 months ago
27:47

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

646 views

·

6 months ago
19:14

FL: How Do I Deal With Relapse?

SOHO Brazil 2024

B. Kahl

454 views

·

4 months ago
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

876 views

·

6 months ago
12:47

ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"

Insights from 2023 ASCO® Annual Meeting

S. O'Brien, C. Coombs

2.1K views

·

1 year ago
13:40

Summary of Bispecific Antibodies for Follicular Lymphoma

UChicago Medicine

D. Russler-Germain

358 views

·

3 months ago
21:12

3L in CLL: The Best Options in a Patient Double-Refractory to Covale…

SOHO Brazil 2024

J. Burger

488 views

·

4 months ago
17:05

Frontline CLL Learnings From Phase 3 RESONATE-2, iLLUMINATE, and E19…

Cleveland Clinic Taussig Cancer Institute

A. Winter

2.4K views

·

1 year ago
16:34

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

612 views

·

5 months ago
13:56

Follicular Lymphoma Management: What Is the New Order?

SOHO 2023 Eleventh Annual Meeting

B. Kahl

910 views

·

1 year ago
03:06

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

310 views

·

4 months ago
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

357 views

·

1 month ago
17:24

ESMO 2024 Summary: Updates in the Treatment of MCL

2024 ESMO Annual Meeting Insights Hub

G. Hess

214 views

·

1 month ago
35:27

Updates on Management of DLBCL

Louisville Hematology Highlights

J. Leonard

696 views

·

8 months ago
06:33

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

Christopher Flowers

515 views

·

7 months ago